Literature DB >> 2536905

Neuronal antinuclear antibodies in a patient with Lambert-Eaton myasthenic syndrome and small-cell lung carcinoma.

E J Dropcho1, C Stanton, S J Oh.   

Abstract

A patient with small-cell lung carcinoma and the Lambert-Eaton myasthenic syndrome had circulating neuronal antinuclear antibodies. Serum stained the nuclei of all neurons in sections of human brain and identified a closely spaced group of 33-39 kDa proteins in immunoblots of human neuronal nuclei. These autoantibodies are indistinguishable from those recently identified in patients with paraneoplastic subacute sensory neuronopathy.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2536905     DOI: 10.1212/wnl.39.2.249

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  5 in total

1.  Anti-glial nuclear antibody: marker of lung cancer-related paraneoplastic neurological syndromes.

Authors:  F Graus; A Vincent; P Pozo-Rosich; L Sabater; A Saiz; B Lang; J Dalmau
Journal:  J Neuroimmunol       Date:  2005-08       Impact factor: 3.478

2.  Paraneoplastic chronic intestinal pseudoobstruction as a rare complication of bronchial carcinoid.

Authors:  A Gerl; M Storck; A Schalhorn; J Müller-Höcker; K W Jauch; F W Schildberg; W Wilmanns
Journal:  Gut       Date:  1992-07       Impact factor: 23.059

3.  Multiple paraneoplastic syndromes in a patient with antibodies to neuronal nucleoproteins (anti-Hu).

Authors:  F Heidenreich; R Schober; U Brinck; H P Hartung
Journal:  J Neurol       Date:  1995-03       Impact factor: 4.849

4.  Sensory neuronopathy and small cell lung cancer: antineuronal antibody reacting with neuroblastoma cells.

Authors:  K O Lövblad; J Boucraut; S Bourdenet; D Burger; D Bernard; F Regli; A J Steck
Journal:  J Neurol       Date:  1993-06       Impact factor: 4.849

5.  Adenocarcinoma of Lung Presenting as Lambert-Eaton Myasthenic Syndrome.

Authors:  Sumera Bukhari; Rabia Soomro; Shaikh Fawwad; Chikezie Alvarez; Sara Wallach
Journal:  J Investig Med High Impact Case Rep       Date:  2017-07-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.